Vanguard Investments Australia
CLBT icon

Vanguard Investments Australia’s Cellebrite CLBT Stock Holding History

Vanguard Investments Australia’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Hold
25,738
– – ﹤0.01% 1793
2026
Q1 		$355K Buy
+25,738
New +$388K ﹤0.01% 1759

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Vanguard Investments Australia's CLBT Position: Q2 2026 in Review

Vanguard Investments Australia held its Cellebrite (CLBT) position steady in Q2 2026 at 25,738 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Vanguard Investments Australia first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Vanguard Investments Australia held 25,738 shares of Cellebrite worth $376K as of Q2 2026.
  • Vanguard Investments Australia left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1793 holding.
  • Vanguard Investments Australia first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.